In 1992, the business Medpro Pharmaceutica / Cipla Medpro, one of SA’s first generic medicines companies was founded.

After strategically aligning the growing business with Cipla, India’s largest pharmaceutical company, Cipla Medpro is currently the fourth largest pharmaceutical company in South Africa. 

The company offers medicines and products across a broad range of categories, including some of today’s most challenging disease categories such as cardio-respiratory, diabetes, oncology, psychiatry and HIV/Aids.
Cipla Medpro's strong relationship with Cipla India and its own innovations have been key to the company's  continuously increasing market share. 

Furthermore Cipla Medpro is the only local provider of a full spectrum of products covering the diagnostics, insulins, oral medication and Over The Counter medications for diabetes.

In December 2005, in one of the largest transactions ever undertaken in the local pharmaceutical industry, the company was listed on the JSE.

In August 2007 and following a board decision to divest of its consumer products businesses to focus purely on pharmaceuticals, Cipla CEO and founder Jerome Smith was appointed Group CEO. In October that year Cipla Medpro Financial Director Chris Aucamp was appointed Group CFO.

Cipla employs a sales force of 175, as well as 34 pharmacists and seven doctors within its pharma, OTC and veterinary teams.